Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 135Neoplasms 37Pancreatic Neoplasms 34Stomach Neoplasms 27Colonic Neoplasms 23Neoplasm Metastasis 20Rectal Neoplasms 17Carcinoma, Non-Small-Cell Lung 15Esophageal Neoplasms 10Cholangiocarcinoma 10Adenocarcinoma 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Biliary Tract Neoplasms 8Adenocarcinoma Of Esophagus 8Ovarian Neoplasms 7Triple Negative Breast Neoplasms 6Gallbladder Neoplasms 6Esophageal Squamous Cell Carcinoma 6Gastrointestinal Neoplasms 5Digestive System Neoplasms 5Breast Neoplasms 5Advanced Solid Tumors 5Squamous Cell Carcinoma of Head and Neck 4Solid Tumors 4Melanoma 4Intestinal Neoplasms 4Carcinoma, Pancreatic Ductal 4Carcinoma, Hepatocellular 4Advanced Solid Tumor 4Small Cell Lung Carcinoma 3

Interventions

Lenalidomide 2tafasitamab 1brivanib 1Valganciclovir 1N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo(4,5-d)pyrrolo(2,3b)pyridine-7-carboxamide 1Leucovorin 1Irinotecan 1Fluorouracil 1Dexamethasone 1Bortezomib 1BMS-833923 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Pyloric Stenosis, Hypertrophic × Leucovorin × Clear all
NCT01046864 2014-09-16

Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)

Bristol-Myers Squibb

Phase 1 Completed
49 enrolled

Pyloric Stenosis, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡